Patent intelligence · US
US 11214569
Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof
Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof
Patent details — US 11214569
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 4, 2022
- Expiration
- Dec 30, 2041
- Applicant
- Lenz Therapeutics, Inc.
- Claims
- 22
- CPC classes
- A61K, A61K31/439, A61K31/661, A61K47/40
Quick answer
US 11214569 (Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof) is held by Lenz Therapeutics, Inc.. Status: granted. Granted Jan 4, 2022. Expires Dec 30, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Lenz Therapeutics, Inc.
- Grant date
- Expiration
- Claims
- 22
- CPC classes
- A61K, A61K31/439, A61K31/661, A61K47/40, A61P, A61P27/06
More from Lenz Therapeutics, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12414942
Compositions, methods, and systems for treating presbyopia
granted -
US 12180206
Aceclidine derivatives, compositions thereof and methods of use thereof
granted -
US 12128036
Compositions and methods for storage stable ophthalmic drugs
granted -
US 11648247
Compositions and methods for the treatment of presbyopia
granted -
US 11344538
Methods for the treatment of myopia
granted -
US 11273150
Compositions and methods for the treatment of presbyopia
granted -
US 11179328
Compositions and methods for the treatment of presbyopia
granted
Frequently asked questions
What is US patent 11214569?
US 11214569 (Prodrugs of quinuclidine ring-containing muscarinic agonists and compositions and methods thereof) is held by Lenz Therapeutics, Inc.. Status: granted. Granted Jan 4, 2022. Expires Dec 30, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11214569?
Lenz Therapeutics, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 20 pharmaceutical patents for this assignee.
When does US 11214569 expire?
Our index shows an expiration date of Dec 30, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.